MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress

LONDON and NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therap...

Related Keywords

Belgium ,Brussels ,Bruxelles Capitale ,London ,City Of ,United Kingdom ,Jason Braco ,European Society Of Gene ,Nasdaq ,Meiragtx Holdings ,Lifesci Communications ,European Society ,Cell Therapy ,Alexandria Forbes ,Preclinical Efficacy ,Gene Therapy ,Sensory Disease ,Xerostomia Specific Questionnaire ,Global Rate ,Change Questionnaire ,Adeno Associated Virus ,Human Embryonic Kidney ,Good Manufacturing Practice Compatible ,Central Composite Design ,Host Cell Proteins ,Private Securities Litigation Reform Act ,Quarterly Report ,